Carisma Therapeutics Inc. Capital Reinvestment Ratio

Latest as of March 2022: 0.03x

Carisma Therapeutics Inc. capital reinvestment ratio. Carisma Therapeutics Inc. (CARM) has a Capital Reinvestment Ratio of 0.03x as of March 2022, meaning it reinvests 0% of its operating cash flow ($34.60 Million) in capital expenditures ($1.01 Million). Check Carisma Therapeutics Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$34.60 Million

USD

Capital Expenditures

$1.01 Million

USD

Data as of

Mar 2022

Most recent filing

Carisma Therapeutics Inc. Capital Reinvestment Ratio by Year (None–None)

Carisma Therapeutics Inc. capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash efficiency ratio of Carisma Therapeutics Inc..

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow